©2009 GlaxoSmithKline. All Rights Reserved. This alli site is intended for Hong Kong residents only.本愛纖伴®網站只供香港居民使用。 alli 及愛纖伴為葛蘭素史克集團所擁有之註冊商標 N11ALL001/02-2011
alli愛纖伴為非醫生處方藥物，請於服用前細閱隨包裝附上的產品資料。
- Rössner S, Sjöström L, Noack R, et al. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res. 2000; 8: 49-61
- Anderson JW, Schwartz SM, Hauptman J, et al. Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial. Ann Pharmacother 2006; 40: 1717-1723
- Hauptman J, Lucas C, Boldrin MN, et al. Orlistat in the long-term treatment of obesity in primary care settings. Arch Fam Med. 2000; 9: 160-167